Confirm delete?

Bertin Bioreagent
logo

Search

Contact Us

ApoA1 (human) ELISA Kit

  • Zoom
    ApoA1 (human) ELISA Kit
  • ApoA1 (human) ELISA Kit
Cat No: 501080
Cayman
€495.00
Price is excluding VAT and does not include packaging neither shipping

Apolipoprotein A1 (ApoA1), a major component of high-density lipoproteins, acts as an acceptor for sequential transfers of phospholipids and free cholesterol from peripheral tissues and transports cholesterol to the liver and other tissues for excretio...

More
: 96 wells

This product can only be bought through Cayman Chemical. Please contact us.

- +
Territorial Availability: Available through Bertin Technologies only in Europe
Technical Warning: Check the Additional Items Required section of this kit booklet to verify if UltraPure Water (Milli-Q or equivalent) is needed for this assay
Product Overview:
Apolipoprotein A1 (ApoA1), a major component of high-density lipoproteins, acts as an acceptor for sequential transfers of phospholipids and free cholesterol from peripheral tissues and transports cholesterol to the liver and other tissues for excretion and steroidogenesis. Serum ApoA1 levels are inversely related to the risk of developing atherosclerosis. Decreased ApoA1 levels have also been associated with Tangier disease, familial hypolipoproteinemia, and systemic non-neuropathic amyloidosis. Cayman's ApoA1 (human) ELISA Kit is a competitive assay that can be used to measure ApoA1 in plasma and serum without prior sample purification. Normal human plasma and serum levels of ApoA1 range from 0.9-2.0 mg/ml. The assay has a range from 0.078-10 µg/ml and a sensitivity (80% B/B0) of approximately 0.2 µg/ml.
Apolipoprotein A1 (ApoA1), a major component of high-density lipoproteins, acts as an acceptor for sequential transfers of phospholipids and free cholesterol from peripheral tissues and transports cholesterol to the liver and other tissues for excretion and steroidogenesis. Serum ApoA1 levels are inversely related to the risk of developing atherosclerosis. Decreased ApoA1 levels have also been associated with Tangier disease, familial hypolipoproteinemia, and systemic non-neuropathic amyloidosis. Cayman's ApoA1 (human) ELISA Kit is a competitive assay that can be used to measure ApoA1 in plasma and serum without prior sample purification. Normal human plasma and serum levels of ApoA1 range from 0.9-2.0 mg/ml. The assay has a range from 0.078-10 µg/ml and a sensitivity (80% B/B0) of approximately 0.2 µg/ml.
Size: 96 wells
Shipping: wet ice
Stability: Store at 4 degrees; shelf life 180 days maximum after production
Custom Code: 3822000002
UNSPSC code: 41116104
UN Number: UN2796

Ajees, A.A., Anantharamaiah, G.M., Mishra, V.K., et al. Crystal structure of human apolipoprotein A-I: Insights into its protective effect against cardiovascular diseases. Proc Natl Acad Sci USA 103(7) 2126-2131 (2006).

Tall, A.R., and Wang, N. Tang

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : ApoA1 (human) ELISA Kit There are 3 products.